Effect on sexual function of a vacuum erection device post-prostatectomy

Canadian Journal of Urology

Volumn 18, Issue 3, 2011, Pages 5721-5725

  Engel, Jason Douglas ^a  

^a GEORGE WASHINGTON UNIVERSITY HOSPITAL   (United States)

Author keywords

Combination therapy; Erectile dysfunction; Penile hardness; Phosphodiesterase inhibitor; Radical prostatectomy; Tadalafil; Vacuum erection device (VED)

Indexed keywords

CARBOLINE DERIVATIVE; PHOSPHODIESTERASE V INHIBITOR; TADALAFIL;

ADULT; APPARATUS, EQUIPMENT AND SUPPLIES; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ERECTILE DYSFUNCTION; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATIENT COMPLIANCE; PENIS ERECTION; PHYSIOLOGY; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SEXUALITY; TREATMENT OUTCOME; VACUUM;

ADULT; CARBOLINES; COMBINED MODALITY THERAPY; EQUIPMENT AND SUPPLIES; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PENILE ERECTION; PHOSPHODIESTERASE 5 INHIBITORS; PROSTATECTOMY; SEXUAL BEHAVIOR; SEXUALITY; TREATMENT OUTCOME; VACUUM;

EID: 80055094440     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Burkhardt JH, Litwin MS, Rose CM et al. Comparing the costs of radiation therapy and radical prostatectomy for the initial treatment of early-stage prostate cancer. J Clin Oncol 2002;20(12):2869-2875.
2. Mulhall J, Land S, Parker M, Waters WB, Flanigan RC. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2005;2(4):532-540.
3. Kendirci M, Mejma J, Hellstrom WJ. Update on erectile dysfunction in prostate cancer patients. Curr Opin Urol 2006;16(3):186-195.
4. Garcia FJ, Brock G. Current state of penile rehabilitation after radical prostatectomy. Curr Opin Urol 2010;20(3):234-240.
5. Carrier S, Zvara P, Nunes L, Kour NW, Rehman J, Lue TF. Regeneration of nitric oxide synthase-containing nerves after cavernous nerve neurotomy in the rat. J Urol 1995;153(5):1722-1727.
6. Toda N, Ayajiki K, Okamura T. Nitric oxide and penile erectile function. Pharmacol Ther 2005;106(2):233-266.
7. Ghalayini IF. Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility. Int J Impot Res 2004;16(6):459-469.
8. McCullough AR, Levine LA, Padma-Nathan H. Return of nocturnal erections and erectile function after bilateral nervesparing radical prostatectomy in men treated nightly with sildenafil citrate: subanalysis of a longitudinal randomized doubleblind placebo-controlled trial. J Sex Med 2008;5(2):476-484.
9. Hu WL, HU LQ, Sonh J et al. Fibrosis of corpus cavernosum in animals following cavernous nerve ablation. Asian J Androl 2004;6(2):111-116.
10. Padma-Nathan H, McCullough AR, Levine LA et al. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res 2008;20(5):479-486.
11. Nehra AJ, Grantmyre J, Nadel A, Thibonnier M, Brock G. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy. J Urol 2005;173(6):2067-2071.
12. Montorsi F, Nathan HP, McCullough A et al. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. J Urol 2004;172(3):1036-1041.
13. Montorsi F, Guazzoni G, Strambi LF et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 1997;158(4):1408-1410.
14. Costabile RA, Spevak M, Fishman IJ et al. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. J Urol 1998;160(4):1325-1328.
15. Zippe CD, Pahlajani G. Vacuum erection devices to treat erectile dysfunction and early penile rehabilitation following radical prostatectomy. Curr Urol Rep 2008;9(6):506-513.
16. Kohler TS, Pedro R, Hendlin K et al. A pilot stuudy on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int 2007;100(4):858-862.
17. Canguren O, Bailen J, Fredriksson W, Bock D, Burnett AL. Combination of vacuum erection device and PDE5 inhibitors as salvage therapy in PDE5 inhibitor nonresponders with erectile dysfunction. J Sex Med 2009;6(9):2561-2567.
18. McCullough AR, Levine LA, Padma-Nathan H. Return of nocturnal erections and erectile fubction after biltaeral nervesparing radical prostatectomy in men treated nightly with sildenafil citrate: subanalysis of a longitudinal randomized doubleblind placebo-controlled trial. J Sex Med 2008:5(2):476-484.
19. Bannowsky A, Schulze H, van der Horst C, Hautmann S, Junemann KP. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int 2008;101(10):279-283.
20. Salonia A, Gallina A, Zanni G et al. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical proatatectomy. Eur Urol 2008;53(3):564-570.
21. Hatzimouratidis K, Burnett AL, Hatzichristou D, McCullough AR, Montorsi F, Mulhall JP. Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction; a critical analysis of the basic science rationale and clinical application. Eur Urol 2009;55(2):334-347.
22. Lee DJ, Cheetham P Badani KK. Penile rehabilitation protocol after robot-assisted radical prostatectomy:assessment of compliance with phosphodiesterase type 5 inhibitor therapy and effect on early potency. BJU Int 2010;105(3):382-388.